Expanding the Role of Prescription Drug Monitoring Programs
Ashlee N. Mattingly
原始摘要（英文原文）· Original abstract
This Viewpoint proposes an expansion of state-run prescription-drug monitoring programs to meet the need for broader pharmacovigilance given the shift to alternative payment methods that bypass traditional insurance claims.